Presentation Overview
Crestone, Inc. presents at the 29th ECCMID in Amsterdam, Netherlands. Oral Session: Mode of Action, Spectrum of Activity, and Preclinical in vivo Efficacy of CRS0540, a PolC DNA Polymerase Inhibitor of Resistant Gram-positive Pathogens
